Modern combined hormonal therapy in early postmenopause women
Aim. To study the effects of hormone replacement therapy (HRT) with a combination of estradiol and drospirenone on cardiometabolic risk levels and subclinical vascular pathology among women in early postmenopause. Material and methods. In total, 84 women in early postmenopause, who had given informe...
Main Authors: | V. B. Mychka, M. Yu. Kirillova, I. V. Kuznetsova, N. A. Voychenko, A. A. Fedorovich, T. V. Balakhonova, Yu. V. Prokhorova, V. A. Vyshivanyuk |
---|---|
Format: | Article |
Language: | Russian |
Published: |
«SILICEA-POLIGRAF» LLC
2012-08-01
|
Series: | Кардиоваскулярная терапия и профилактика |
Subjects: | |
Online Access: | https://cardiovascular.elpub.ru/jour/article/view/1864 |
Similar Items
-
“Female issue” in cardiology
by: V. B. Mychka, et al.
Published: (2010-08-01) -
Therapeutic aspects of hormone replacement therapy in postmenopausal women with metabolic syndrome: cardiologist’s opinion
by: T. V. Adasheva, et al.
Published: (2009-08-01) -
Cardiovascular risk factors in women and the role of sex hormones
by: S. V. Yureneva, et al.
Published: (2011-08-01) -
Hormone replacement therapy effectiveness and safety in postmenopausal women with metabolic syndrome
by: O. N. Poryvkina, et al.
Published: (2009-02-01) -
An imidazoline receptor agonist, moxonidine, in optimization of arterial hypertension treatment among postmenopausal women
by: A. B. Bakhshaliev, et al.
Published: (2006-02-01)